Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Colombel

Showing results (291-300 of 368) with videos related to

Pageof 37
Sort By:
Clinical and Vaccine Immunology : CVI|October 31, 2008
Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannanB Sendid, N Dotan, S Nseir, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
Chronic gastritis: prevalence in the French population. CIRIGF Potet, C Florent, E Benhamou, et al.
Gut|December 1, 1995
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesT Sahmoud, G Hoctin-Boes, R Modigliani, et al.
Mucosal Immunology|October 8, 2015
Role of mannose-binding lectin in intestinal homeostasis and fungal eliminationL Choteau, M Parny, N François, et al.
Gut|October 1, 1994
Incidence of inflammatory bowel disease in northern France (1988-1990)C Gower-Rousseau, J L Salomez, J L Dupas, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitisD Wolf, G D'Haens, W J Sandborn, et al.
Inflammatory Bowel Diseases|August 24, 1999
Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitisB Louvet, M P Buisine, P Desreumaux, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988]J F Colombel, J L Dupas, A Cortot, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2004
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's diseaseE Louis, Z El Ghoul, S Vermeire, et al.
Current Medical Research and Opinion|February 27, 2013
Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's diseaseW J Sandborn, J-F Colombel, G D'Haens, et al.
Pageof 37

Showing results (291-300 of 368) with videos related to

Sort By:
Pageof 37
Clinical and Vaccine Immunology : CVI|October 31, 2008
Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannanB Sendid, N Dotan, S Nseir, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
Chronic gastritis: prevalence in the French population. CIRIGF Potet, C Florent, E Benhamou, et al.
Gut|December 1, 1995
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesT Sahmoud, G Hoctin-Boes, R Modigliani, et al.
Mucosal Immunology|October 8, 2015
Role of mannose-binding lectin in intestinal homeostasis and fungal eliminationL Choteau, M Parny, N François, et al.
Gut|October 1, 1994
Incidence of inflammatory bowel disease in northern France (1988-1990)C Gower-Rousseau, J L Salomez, J L Dupas, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitisD Wolf, G D'Haens, W J Sandborn, et al.
Inflammatory Bowel Diseases|August 24, 1999
Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitisB Louvet, M P Buisine, P Desreumaux, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988]J F Colombel, J L Dupas, A Cortot, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2004
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's diseaseE Louis, Z El Ghoul, S Vermeire, et al.
Current Medical Research and Opinion|February 27, 2013
Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's diseaseW J Sandborn, J-F Colombel, G D'Haens, et al.
Pageof 37